• News
  • Stock Screener
  • Small Caps
  • Guru Portfolios
  • Review
  • News
  • Stock Screener
  • Small Caps
  • Guru Portfolios
  • Review
  • X (Twitter)
  • LinkedIn
Stock Screener·Saudi Arabia·Healthcare·4009.SR
Share

Middle East Healthcare Company Stocks

SAR 31.98Last Updated 10.09.2026

Issuer Rating

5/7
Performance

Favourable

Risk

Limited

Recommendation

Hold

Market Cap

SAR 818.49M

SAR 31.98
Key Takeaways

Risk factor

Resilient to price shocks

Data is available to registered users only
Data is available to registered users only

Profitability factor

Good growth

Data is available to registered users only
Data is available to registered users only
Sign up to get free access to key risk and return factors, detailed company valuation, and analyst forecasts
Sign up to access all the key risk and return factors

Risks

  • Default risk
    Data is available to registered users only
  • Volatility
    Data is available to registered users only
  • Selling difficulty
    Data is available to registered users only
  • Stress test
    Data is available to registered users only
  • Country risks
    Data is available to registered users only
  • Other risks
    Data is available to registered users only
Sign up to access detailed risk analysis

About

Middle East Healthcare Company is a prominent medical service provider that manages and operates an extensive network of Saudi German Hospitals throughout the Middle East and North Africa region. These facilities offer comprehensive multi-specialty tertiary care. The company's diverse hospital portfolio includes Saudi German Hospital-Jeddah with 218 beds, Saudi German Hospital-Aseer featuring 400 beds, Saudi German Hospital-Riyadh and Saudi German Hospital-Madinah each equipped with 300 beds, and Saudi German Hospital-Hail providing 150 beds. Expanding its reach further, the network also encompasses Saudi German Hospital-Dammam, offering 150 to 300 beds; Saudi German Hospital-Sanaa and Saudi German Hospital-Dubai, both with 300 beds; Saudi German Hospital-Sharjah, a 50-bed facility; Saudi German Hospital-Ajman, which has between 100 and 200 beds; and Saudi German Hospital-Cairo, accommodating 332 patients. Established in 1988, the company's primary corporate base is situated in Jeddah, Kingdom of Saudi Arabia.

Company Valuation

Fairly valued
4/7

From both historical and forecast perspectives, the stock is fairly priced compared to similar stocks. Specifically, the stock is fairly valued on P/E, neutral on EV/EBIT

Data is available to registered users only
Sign up to access detailed valuation

Target Price

Neutral
4/7

The average target price of 4009.SR is 54.7 and suggests 70.8% upside potential. Usually, this means a BUY recommendation among investment firms, or a recommendation to i

Data is available to registered users only
Sign up to access analyst forecasts

Risks

  • Default risk
    Data is available to registered users only
  • Volatility
    Data is available to registered users only
  • Selling difficulty
    Data is available to registered users only
  • Stress test
    Data is available to registered users only
  • Country risks
    Data is available to registered users only
  • Other risks
    Data is available to registered users only
Sign up to access detailed risk analysis

Trending

12.09.2026 16:01

Small caps last week: Chewy's earnings miss, Signet's best day ever, AE rethinks ads

12.09.2026 13:01

The iPhone Reboot, the AGI Era, and Silicon Valley's Right Turn

12.09.2026 05:06

Spam from OpenAI's AI agents disrupted the developer service for four days

12.09.2026 03:52

Citrini, the founder who spooked the market with his prediction of AI threats, has sold the company. What's next?

12.09.2026 03:18

Dell's stock reached an all-time high. Dell has joined the ranks of the world's top three richest people

X-channel

Buy

Sell

0 more stocks

Company

  • About
  • Contributors
  • Contacts
  • Legal Information

Social media

  • X (Twitter)
  • LinkedIn

Services

  • Stock Screener
  • Guru Portfolios
  • X (Twitter)
  • LinkedIn
Oninvest© 2026